What are the risk factors and settings for non‐alcoholic fatty liver disease in Asia–Pacific?

Jian‐Gao Fan, Toshiji Saibara, Shivakumar Chitturi, Byong Ik Kim, Joseph J.�y. Sung, Anuchit Chutaputti, the Asia–Pacific Working Party for NafldJournal of Gastroenterology and Hepatology 2007 · DOI

TL;DR

This review highlights that non-alcoholic fatty liver disease (NAFLD) is a growing concern in the Asia-Pacific region, with risk factors mirroring those in Western countries, particularly obesity and type 2 diabetes. The paper emphasizes the critical role of metabolic syndrome and the need for public health initiatives to combat the rising "diabesity" epidemic.

What Problem Does This Paper Address?

Non-alcoholic fatty liver disease (NAFLD) was historically considered a condition primarily affecting affluent Western populations. However, the paper addresses the increasing prevalence of NAFLD in the Asia-Pacific region, driven by the global rise in obesity and metabolic syndrome. The authors aim to provide a comprehensive overview of the specific risk factors and epidemiological settings of NAFLD within this diverse region, noting that existing definitions and criteria for obesity and metabolic syndrome may need adaptation for Asian populations. They also explore the complex interplay between NAFLD and metabolic disorders, questioning whether NAFLD is merely a symptom of metabolic syndrome or if it can also contribute to its development.

Methods

This paper is a comprehensive review of existing literature, drawing upon large community-based studies, ultrasonography findings, case-control series, and prospective longitudinal studies. The authors synthesized data from various Asian countries to analyze the prevalence, risk factors, and clinical implications of NAFLD. They specifically discuss the adaptation of diagnostic criteria, such as Body Mass Index (BMI) and waist circumference, for Asian populations, referencing studies that have proposed modified thresholds.

Datasets

Not discussed in the paper. The paper is a review of existing studies and does not present new data collection or analysis.

Key Insights and Ideas

  • NAFLD is a Global, Not Just Western, Problem: The paper strongly refutes the notion that NAFLD is confined to Western countries, demonstrating its significant and increasing prevalence across the Asia-Pacific.
  • Metabolic Syndrome is the Central Player: NAFLD is presented not just as a liver condition but as a hepatic manifestation of metabolic syndrome, with insulin resistance being a key underlying factor.
  • Asia-Pacific Faces a "Diabesity" Crisis: The confluence of rising obesity and type 2 diabetes in the region places a substantial portion of the population at risk for NAFLD and its severe consequences.
  • Defining Obesity Differently Matters: The paper highlights that standard Western criteria for obesity (BMI, waist circumference) may not accurately capture the risk in Asian populations, necessitating region-specific definitions.
  • NAFLD's Impact Extends Beyond the Liver: While NAFLD itself can lead to liver damage, it's also linked to increased risks of diabetes and cardiovascular disease, suggesting a bidirectional relationship with metabolic health.
  • Early Intervention is Crucial: The review underscores the need for public health initiatives to address the "diabesity" epidemic, which is the root cause of NAFLD and metabolic syndrome.

Key Results

  • The prevalence of NAFLD in Asia ranges from 12% to 24%, with significant increases observed in China and Japan over the last 10-15 years.
  • Risk factors for NAFLD in Asians largely mirror those in the West, including age, type 2 diabetes mellitus (T2DM), and hyperlipidemia.
  • Differences in central and overall obesity prevalence between Asians and Westerners are attributed to variations in defining waist circumference and BMI.
  • The presence of metabolic syndrome components, particularly central obesity and overall obesity, is strongly associated with NAFLD.
  • Studies indicate that NAFLD is closely linked to insulin resistance, with hyperinsulinemia and elevated HOMA-IR levels observed in patients with NAFLD.
  • The paper cites studies showing that NAFLD can precede or coexist with metabolic disorders, suggesting it may be an early predictor of metabolic issues.

Limitations and Future Work

  • Adaptation of Criteria: While the paper discusses the need for adapted criteria for obesity and metabolic syndrome in Asians, it acknowledges that subtle ethnic differences may still exist within the broad Asian population.
  • Temporal Relationship: The exact temporal relationship between the development of metabolic syndrome and NAFLD is not fully characterized, though evidence suggests a strong bidirectional link.
  • Beyond Hepatic Consequences: The authors call for a broader perspective on NAFLD, moving beyond its direct hepatic consequences to understand its impact on cardiovascular diseases and malignancy.
  • Public Health Initiatives: The paper strongly advocates for public health initiatives to combat the "diabesity" epidemic, emphasizing the need to halt or reverse the rising trends of obesity and diabetes.
  • Further Research: Future studies are needed to explore the similarities and differences in NAFLD presentation across the diverse Asia-Pacific region and to further elucidate the impact of NAFLD on cardiovascular risks and malignancy.

Summary updated

Abstract

The risk factors and settings for non-alcoholic fatty liver disease (NAFLD) in Asians are reviewed comprehensively. Based particularly on large community-based studies using ultrasonography, case-control series and prospective longitudinal studies, the prevalence of NAFLD in Asia is between 12% and 24%, depending on age, gender, locality and ethnicity. Further, the prevalence in China and Japan has nearly doubled in the last 10-15 years. A detailed analysis of these data shows that NAFLD risk factors for Asians resemble those in the West for age at presentation, prevalence of type 2 diabetes mellitus (T2DM) and hyperlipidemia. The apparent differences in prevalence of central obesity and overall obesity are related to criteria used to define waist circumference and body mass index (BMI), respectively. The strongest associations are with components of the metabolic syndrome, particularly the combined presence of central obesity and obesity. Non-alcoholic fatty liver disease appears to be associated with long-standing insulin resistance and likely represents the hepatic manifestation of metabolic syndrome. Not surprisingly therefore, Asians with NAFLD are at high risk of developing diabetes and cardiovascular disease. Conversely, metabolic syndrome may precede the diagnosis of NAFLD. The increasing prevalence of obesity, coupled with T2DM, dyslipidemia, hypertension and ultimately metabolic syndrome puts more than half the world's population at risk of developing NAFLD/non-alcoholic steatohepatitis/cirrhosis in the coming decades. Public health initiatives are clearly imperative to halt or reverse the global 'diabesity' pandemic, the underlying basis of NAFLD and metabolic syndrome. In addition, a perspective of NAFLD beyond its hepatic consequences is now warranted; this needs to be considered in relation to management guidelines for affected individuals.
BibTeX
@article{fan2007what,
  author = {Jian‐Gao Fan and Toshiji Saibara and Shivakumar Chitturi and Byong Ik Kim and Joseph J.�Y. Sung and Anuchit Chutaputti and the Asia–Pacific Working Party for NAFLD},
  title = {{What are the risk factors and settings for non‐alcoholic fatty liver disease in Asia–Pacific?}},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2007},
  doi = {10.1111/j.1440-1746.2007.04952.x},
}
Figure